University Clermont Auvergne
Also known as: Adeline BLOT | Auvergne Univeristy | Bruno PEREIRA, Clinical Research Direction and innovation, Clermont-Ferrand Hospital | CENTRE DE PHARMACOLOGIE CLINIQUE | Centre de Pharmacologie Clinique - Clermont-Ferrand (France) | Centre de Recherche en Nutrition Humaine. Clermont-Ferrand, France | Centre de Recherche en Nutrition Humaine d'Auvergne | Centre d'Investigation Clinique INSERM 501, Clermont-Ferrand, France | Centre d'Ophtalmologie Blatin | Centre Hospitalier CLERMOND FERRAND | Centre Hospitalier Sainte Marie de Clermont Ferrand | CHRU Gabriel Montpied Clermont-Ferrand | CHU Clermont-Ferrand, Inserm, Neuro-Dol | CHU de Clermont Ferrand | CHU de Clermont-Ferrand | CHU Estaing - Clermont Ferrant | CHU Gabriel-Montpied, Clermont-Ferrand | CIC Clermont-Ferrand CPC Centre de Pharmacologie clinique | CIC-CPC | CIC-CPC Clermont-Ferrand | CIC Inserm 1405, University Hospital Clermont-Ferrand, France | Clermont-Ferrand (FR), University College Hospital | Clermont-Ferrand Hospital | ClermontFerrandUH | CPC/CIC-INSERM 501 | CREPS Auvergne Rhône-Alpes / Vichy | CREPS Vichy Auvergne | Dr. Betty JEAN (PH) | Dr Christian DUALE | Dr Christian DUALE/ Center of clinical pharmacology/CIC Inserm-501 - Investigator | Dr Dominique JOLY / Dr Christine VILLATTE | Dr Xavier DURANDO/Dr Marie-Ange MOURET/Dr Christine VILLATTE, Jean-Perrin Cancer Center, Clermont-Ferrand Hospital | Gilles DUCHEIX, Clinical Pharmacology Center, Inserm 1405, Clermont-Ferrand Hospital | GIRCI Auvergne Rhône-Alpes | Hopital Gabriel Montpied | Hopital Gabriel Montpied (Clermont-Ferrand) | Hôpital Gabriel Montpied, University Hospital of Clermont-Ferrand | Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques | Musculo-skeletal and Neurological thoracic imaging service of Clermont-Ferrand Hospital (France) | Pôle Anesthésie Réanimation / Service de Chirurgie Cardio-Vasculaire | Pr Jeannot SCHIMDT, Emergency Department, Clermont-Ferrand Hospital | Service d'Anesthésie-Réanimation, Pôle Médecine Périopératoire - Hôpital Estaing, CHU de Clermont-Ferrand | Université Clermont-Auvergne | Université d'Auvergne | University Clermont Auvergne , Faculté de Chirurgie dentaire | University Hospital, Clermont-Ferrand | University of Clermont-Auvergne
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2000Last known activity
Jan 31, 2026
Timeline
1510s
- Jan 1, 1519
University Clermont Auvergne— Founded
Drugs by trial phase (154 distinct, 180 trials)
Phase 4 (46 own, 0 via acquisition)
Phase 3 (30 own, 0 via acquisition)
Phase 2 (40 own, 0 via acquisition)
Phase 1 (10 own, 0 via acquisition)
Indications
Studied for
- Acute Kidney Injury
- Acute Lung Injury
- Acute Pain
- Agnosia
- Alzheimer Disease
- Anxiety Disorders
- Apnea
- Arterial Occlusive Diseases
- Atherosclerosis
- Avitaminosis
- Back Pain
- Bacterial Infections
- Bone Diseases, Metabolic
- Brain Death
- Brain Injuries
- Brain Injuries, Traumatic
- Bronchitis
- Bronchitis, Chronic
- Calculi
- Chronic Pain
- Communicable Diseases
- Coronary Artery Disease
- Critical Illness
- Crohn Disease
- Delirium
- Disease
- Disruptive, Impulse Control, and Conduct Disorders
- Dystonia
- Dystonic Disorders
- Edema
- Emergencies
- Endometriosis
- Epilepsy
- Essential Tremor
- Eye Infections
- Eye Infections, Bacterial
- Fibromyalgia
- Fibrosis
- Fractures, Bone
- Gaucher Disease
- Heart Failure
- Hematologic Neoplasms
- Hemiplegia
- Hemorrhage
- Hepatitis C
- Hyperalgesia
- Hyperkalemia
- Hypertension
- Hypertension, Pulmonary
- Hypogonadism
- Hypotension
- Hypovolemia
- Infections
- Inflammation
- Intervertebral Disc Degeneration
- Intervertebral Disc Displacement
- Intracranial Hypertension
- Irritable Bowel Syndrome
- Kidney Failure, Chronic
- Leg Injuries
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Low Back Pain
- Lymphoma
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Peripheral
- Malnutrition
- Meningitis
- Multiple Myeloma
- Multiple Sclerosis
- Muscle Spasticity
- Myocardial Ischemia
- Neoplasms
- Neoplasms, Plasma Cell
- Neovascularization, Pathologic
- Neuralgia
- Neuroblastoma
- Obesity
- Osteoporosis
- Overweight
- Parkinson Disease
- Peanut Hypersensitivity
- Peripheral Nervous System Diseases
- Polycystic Ovary Syndrome
- Postoperative Pain
- Premature Birth
- Pseudomonas Infections
- Psychomotor Agitation
- Pulmonary Edema
- Pyelonephritis
- Recurrence
- Renal Insufficiency
- Respiratory Aspiration
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Retinal Neoplasms
- Retinoblastoma
- Rupture
- Sclerosis
Recent trials (50)
- NCT07085624CollaboratorN/AJan 31, 2026
- NCT07292012OfficialPhase 4Jan 31, 2026
- NCT07205731Lead sponsorPhase 2Oct 31, 2025
- NCT06917651OfficialPhase 3Apr 22, 2025
- NCT06917651Lead sponsorPhase 3Apr 22, 2025
- NCT06861075OfficialN/AMar 1, 2025
- NCT06861075Lead sponsorN/AMar 1, 2025
- NCT06612866CollaboratorN/AOct 30, 2024
- NCT06642844CollaboratorPhase 3Oct 30, 2024
- NCT06612866OfficialN/AOct 30, 2024
- NCT06649474Lead sponsorN/ASep 6, 2024
- NCT06444919OfficialPhase 4Sep 1, 2024
- NCT06444919Lead sponsorPhase 4Sep 1, 2024
- NCT06499727CollaboratorPhase 4Jul 15, 2024
- NCT06498505CollaboratorPhase 4Jul 15, 2024
Details
- Founded
- Clermont-Ferrand, FR Jan 1, 1519
- Last known activity
- Jan 31, 2026
Notes
--- Pre-folding founded info: 1937-06-01 Clermont-Ferrand FR https://en.wikipedia.org/wiki/University_of_Clermont_Auvergne ---